The proposed formulation for treatment of skin wounds or burns pertains to medicine and concerns the application of hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine in the treatment of skin wounds or burns as a medicinal product for topical use. In preferred embodiments, the formulation contains hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine at 0.02-0.5 weight % as the active ingredient, with a pharmaceutically acceptable excipient/excipients making up the rest. In specific embodiments, the formulation can be provided in the form of solution or gel. The formulation contributes to rapid healing of skin wounds and burns by stimulating tissue regeneration processes in the affected area and reducing the severity of productive inflammation.
